Ilyang Pharmaceutical Co.,Ltd total revenue, net income and dynamics of changes in South Korean won today
Ilyang Pharmaceutical Co.,Ltd net revenue for today is 82 085 839 630 ₩. Net income Ilyang Pharmaceutical Co.,Ltd - 399 600 780 ₩. Information about net income is used from open sources. The dynamics of Ilyang Pharmaceutical Co.,Ltd net income went up. The change was 80 168 370 ₩. Graph of finance company Ilyang Pharmaceutical Co.,Ltd. The financial report chart on our website displays information by dates from 31/03/2019 to 31/03/2021. The value of Ilyang Pharmaceutical Co.,Ltd assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The dates of the latest financial statements of Ilyang Pharmaceutical Co.,Ltd: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Ilyang Pharmaceutical Co.,Ltd is 31/03/2021. Gross profit Ilyang Pharmaceutical Co.,Ltd is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Ilyang Pharmaceutical Co.,Ltd is 45 530 763 630 ₩
Cost of revenue Ilyang Pharmaceutical Co.,Ltd is the total cost of producing and distributing of products and services of a company. Cost of revenue Ilyang Pharmaceutical Co.,Ltd is 36 555 076 000 ₩ Total revenue Ilyang Pharmaceutical Co.,Ltd refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Ilyang Pharmaceutical Co.,Ltd is 82 085 839 630 ₩ Operating income Ilyang Pharmaceutical Co.,Ltd is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Ilyang Pharmaceutical Co.,Ltd is 8 221 692 880 ₩
Net income Ilyang Pharmaceutical Co.,Ltd is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Ilyang Pharmaceutical Co.,Ltd is 399 600 780 ₩ Current assets Ilyang Pharmaceutical Co.,Ltd is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Ilyang Pharmaceutical Co.,Ltd is 165 422 119 710 ₩ Total assets Ilyang Pharmaceutical Co.,Ltd refers to the total amount of assets owned by a person or entity. Total assets Ilyang Pharmaceutical Co.,Ltd is 452 800 837 310 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
62 592 417 262 650.13 ₩
64 509 931 602 372.63 ₩
65 832 940 252 577.14 ₩
65 144 161 268 251.52 ₩
59 984 335 664 878.22 ₩
61 664 260 624 676.09 ₩
63 665 317 310 871.84 ₩
60 292 322 901 665.32 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
50 253 287 835 310.73 ₩
55 062 619 528 540.13 ₩
75 268 657 100 306.31 ₩
47 675 091 890 226.41 ₩
50 824 301 168 598.10 ₩
61 824 502 388 866.91 ₩
42 417 332 146 274.74 ₩
45 527 830 842 804.56 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
112 845 705 097 960.86 ₩
119 572 551 130 912.77 ₩
141 101 597 352 883.44 ₩
112 819 253 158 477.92 ₩
110 808 636 833 476.33 ₩
123 488 763 013 543 ₩
106 082 649 457 146.58 ₩
105 820 153 744 469.89 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
11 302 591 705 517.58 ₩
11 429 991 340 653.88 ₩
15 672 914 888 296.43 ₩
10 370 197 674 581.78 ₩
8 382 393 091 707.47 ₩
12 263 898 012 955.07 ₩
10 703 340 509 808.43 ₩
13 344 053 408 343.26 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
549 342 395 473.47 ₩
439 132 689 634.05 ₩
6 739 625 078 608.87 ₩
3 331 199 666 257.72 ₩
-2 425 845 092.33 ₩
5 266 093 991 428.07 ₩
1 966 037 977 736.39 ₩
6 496 847 062 657.96 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
5 714 348 523 977.63 ₩
5 791 271 431 232.01 ₩
7 071 084 119 442.46 ₩
7 156 794 288 302.96 ₩
5 941 073 318 255.51 ₩
4 640 825 242 800.80 ₩
7 830 730 347 771.16 ₩
3 376 140 969 219 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
101 543 113 392 443.28 ₩
108 142 559 790 258.89 ₩
125 428 682 464 587.03 ₩
102 449 055 483 896.14 ₩
102 426 243 741 768.86 ₩
111 224 865 000 587.92 ₩
95 379 308 947 338.14 ₩
92 476 100 336 126.62 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
227 410 425 739 885.19 ₩
223 387 616 799 221.34 ₩
263 300 323 949 537.78 ₩
243 672 917 738 975.91 ₩
235 638 428 184 868.66 ₩
247 580 233 000 384.75 ₩
237 260 320 210 387.47 ₩
232 703 463 136 069.06 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
622 478 005 774 331.75 ₩
603 666 086 557 556.88 ₩
644 622 475 300 165.25 ₩
618 484 245 524 432.62 ₩
601 383 100 329 550.88 ₩
615 063 876 021 244.50 ₩
608 583 630 669 251.38 ₩
607 413 067 411 852.62 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
59 487 298 633 025.59 ₩
56 833 164 415 895.39 ₩
57 287 199 501 121.69 ₩
48 723 199 446 924.71 ₩
49 347 082 277 229.77 ₩
33 332 436 875 116.85 ₩
32 163 091 736 736.25 ₩
36 661 076 797 771.54 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
247 903 780 178 931 ₩
249 342 368 387 650.91 ₩
251 596 454 972 905.97 ₩
254 491 883 833 194.38 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
295 177 120 420 639.81 ₩
302 548 057 126 156.50 ₩
304 722 474 001 310.25 ₩
308 058 413 331 165 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
49.08 %
49.19 %
50.07 %
50.72 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
282 190 307 730 211.81 ₩
283 305 483 951 140.56 ₩
283 611 939 782 137.38 ₩
276 055 277 745 122.78 ₩
269 151 254 288 380.72 ₩
271 244 488 029 085.69 ₩
265 982 596 704 989.19 ₩
263 943 441 520 862.31 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
33 536 454 159 147.13 ₩
350 493 497 725.49 ₩
-3 579 882 317 837.89 ₩
19 448 046 570 981.95 ₩
Last revenue report of Ilyang Pharmaceutical Co.,Ltd was 31/03/2021. According to last financial report total revenue in Ilyang Pharmaceutical Co.,Ltd was 112 845 705 097 960.86 South Korean won and changed by +6.64% since last year. Net income in Ilyang Pharmaceutical Co.,Ltd was 549 342 395 473.47 ₩ in last quartal, net income changes to -91.544%.
Current cash Ilyang Pharmaceutical Co.,Ltd - the sum of all of the cash a company has on the date of report. Current cash Ilyang Pharmaceutical Co.,Ltd is 43 272 048 780 ₩
